Drug intelligence / Profile preview

gamma-tocopherol-rich tocopherol mixture

Development stage
Unknown
Lead developer
Rutgers University
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

gamma-tocopherol-rich tocopherol mixture (γ-TmT) is a natural product mixture composed of various forms of vitamin E, typically containing approximately 57% gamma-tocopherol, 24% delta-tocopherol, 13% alpha-tocopherol, and 1.5% beta-tocopherol. Derived as a by-product of vegetable oil refining, γ-TmT has been investigated preclinically and clinically for its anti-inflammatory, anti-oxidative, and anti-carcinogenic properties. It has demonstrated efficacy in animal models of colon, lung, mammary, and prostate cancers, as well as colon inflammation, and has been evaluated in early-phase clinical trials for asthma, airway inflammation, and prostate cancer. Its mechanism of action involves the inhibition of cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2), and 5-lipoxygenase (5-LOX), leading to a reduction in inflammatory mediators such as prostaglandin E2 (PGE2) and leukotriene B4 (LTB4). Additionally, γ-TmT traps reactive nitrogen species, reduces oxidative stress, and modulates downstream signaling pathways (including Nrf2, PTEN, AKT, and Caspase-3) to induce apoptosis and inhibit cell proliferation in cancer cells.

Brand names
Advanced High Gamma Vitamin E
Other names
gamma-tocopherol-rich mixture of tocopherols
02

Targets

ALOX12 (Arachidonate 12-lipoxygenase, 12S type)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ALOX5 (Arachidonate 5-lipoxygenase)

Beyond the preview

Go deeper on gamma-tocopherol-rich tocopherol mixture.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gamma-tocopherol-rich tocopherol mixture.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call